Seeking Alpha

Jon Crowley

 
(In beta) Send Us Feedback»
Title Symbol Long/
Short
Date of
publication
3m from
publication
6m from
publication
1y from
publication
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market NVO Long
6/28/2013
9.6%
17.8%
50.9%
Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry MNTA Long
5/22/2013
12.4%
34.1%
-8.6%
Questcor's Growth Could Lead To Its Downfall QCOR Long
2/6/2013
26.4%
150.0%
139.3%
A Detailed Look At Abbvie ABBV Long
1/27/2013
25.4%
23.7%
31.5%
Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth NVO Long
11/13/2012
9.5%
13.6%
13.7%
AbbVie Beyond Humira ABT Long
6/14/2012
10.1%
6.2%
-39.7%
FDA Recommendations Bode Well For Pfizer PFE Long
5/10/2012
5.8%
7.8%
30.3%
Does Novo Nordisk's Pipeline Justify Its Premium? NVO Long
4/5/2012
1.6%
14.1%
15.6%
Why Novartis Is The Safest Stock In The Pharmaceutical Sector NVS Long
4/2/2012
-0.3%
10.5%
31.3%
For Sale: Pfizer's Growth Prospects PFE Long
3/19/2012
4.8%
12.5%
32.7%